DocDollars

Iovance Biotherapeutics, Inc.

CA · United States · Reporting entity ID 100001448628

Total reported 2019–2025
$28.7M
#249 of 2,960 reporting companies — 0% of all reported industry payments
$258K in general payments across 3,620 records, plus $28.5M in research funding across 2,741 records.

How it breaks down

General payments $258,094
Research funding $28,463,689

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Iovance Biotherapeutics, Inc. reported $28.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #249 of 2,960 reporting companies. 99% of that was research funding and 1% general payments such as consulting, speaking, food and travel. 3,620 general payment records and 2,741 research records were filed.

Common questions about Iovance Biotherapeutics, Inc.

How much has Iovance Biotherapeutics, Inc. paid US doctors?

Iovance Biotherapeutics, Inc. reported $28,721,783 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $258,094 in general payments, $28,463,689 in research funding.

How does Iovance Biotherapeutics, Inc. rank among drug and device companies?

It ranks #249 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Iovance Biotherapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.